Analyst firms · UBS · CLX
UBS CLX price target and rating history
Clorox Company (CLX) · Consumer Discretionary
UBS rates Clorox Company (CLX) Neutral with a $132 price target, as of its latest action on Nov 6, 2023. It has published 4 rating actions on CLX since June 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Neutral
- Price target
- $132
- Median target, all firms
- Too few
- Actions on CLX
- 4
UBS price target on CLX
Every UBS rating on CLX
- Nov 6, 2023
- Feb 4, 2022
- Aug 4, 2021
- Jun 24, 2021
How other firms rate CLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Evercore ISI | In-line | $99 | Nov 2, 2026 |
| Jefferies | Hold | $98 | Jul 28, 2026 |
| BNP Paribas Exane | Neutral | Feb 11, 2026 |
Questions about UBS and CLX
- What is UBS's price target for CLX?
- UBS's latest stated price target for Clorox Company (CLX) is $132, from its action on Nov 6, 2023.
- What is UBS's rating on CLX?
- UBS rates CLX Neutral, a neutral rating, as of Nov 6, 2023.
- When did UBS last change its view on CLX?
- On Nov 6, 2023, UBS upgrades to Neutral from Sell, price target $124 to $132.
More CLX rating histories
- Jefferies4
- Barclays3
- Wells Fargo4
- Citigroup4
- DA Davidson5
- J.P. Morgan3
- Atlantic Equities3
- Morgan Stanley4
- Deutsche Bank5
- Credit Suisse4
All UBS ratingsCLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.